Total Funding
19
49
Total FundingPost-IPO Equity raised
Growth Score
-5 pts
Heat Score
-17 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
254137
QuantoBio is a developer of reagents for immunology research.
About the Company
QuantoBio creates, manufactures, and conducts scientific research. Their products are clinical diagnostic biological reagents. They developed technological foundations for molecular immunology, luminous biochemistry, cellular immunity, and protein immunity. They offer a variety of goods and services, including functional research and diagnostic
reagents based on microRNA expression profiling, as well as microRNA expression profiling and diagnostic reagents. Their clinical products are used for tumour early detection and clinical immune function.These include items from the chemiluminescence series, products for flow cytometry, molecular diagnostics, and protein immunology.
